Home › Funds › TB Alternative Assets Ltd. › ALNY

TB Alternative Assets Ltd. position in ALNY

ALNYLAM PHARMACEUTICALS INC · Health Care

TB Alternative Assets Ltd. reported holding 4,360 shares of ALNY (ALNYLAM PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$1.1M, representing 0.22% of its reported portfolio and ranking #24 among its reported holdings. TB Alternative Assets Ltd. has disclosed ALNY holdings in 5 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)4.36K sh
Reported value held$1.08M
Portfolio Weight0.22%
First reportedQ1 2025
Last changeNew
Updated2026-10-16

Last updated: 2026-10-16 · Source: SEC EDGAR Form 13F-HR

How TB Alternative Assets Ltd.'s ALNY position evolved

TB Alternative Assets Ltd. first disclosed a stake in ALNY in Q1 2025 at 9,168 shares (US$2.5M). Across 5 filings, TB Alternative Assets Ltd. increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 4,360 shares valued at US$1.1M. Notable position changes include a 86% trim in Q2 2025 (shares rose 40% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 9.17K $2.48M New
Q2 2025 1.26K $410.55K Reduce
Q3 2025 1.13K $516.65K Reduce
Q4 2025 1.13K $450.54K Hold
Q3 2026 4.36K $1.08M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ALNY and 13F data

ALNY (ALNYLAM PHARMACEUTICALS INC) is a Health Care company. 36 other funds we track also report a position in ALNY — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.70B), Baillie Gifford & Co (US$734.5M), Orbis Allan Gray Ltd (US$598.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ALNY

All ALNY fund holders →

FAQ

How long has TB Alternative Assets Ltd. held ALNY?

TB Alternative Assets Ltd. has disclosed ALNY holdings in 5 of the last 7 reported quarters, going back to Q1 2025.

What is TB Alternative Assets Ltd.'s current position in ALNY?

As of Q3 2026, TB Alternative Assets Ltd. holds 4.36K shares of ALNY (ALNYLAM PHARMACEUTICALS INC), valued at $1.08M, representing 0.22% of its reported portfolio and ranking #24.

Has TB Alternative Assets Ltd. been buying or selling ALNY?

In the latest 13F filing (Q3 2026), TB Alternative Assets Ltd. newly opened its position in ALNY.

Which other funds hold ALNY?

Other major institutional holders of ALNY include T. Rowe Price Investment Management, Inc., Baillie Gifford & Co, Orbis Allan Gray Ltd, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.